Biblio Discovery — Demo Discovery Service

11 hasil untuk "David Radley"

Menampilkan 1–11 · 0,25 detik · RSS

  1. Artikel Jurnal

    Efficacy and safety outcomes from the MATISSE phase 3 trial of maternal bivalent RSVpreF vaccination among pregnant women vaccinated at 32 to 36 weeks of gestation

    Emma Shittu; Barbara A. Pahud; David Radley dkk.

    Swiss Medical Weekly, Vol. 156 No. 1 · 2026 · Inggris · DOAJ Scopus

    AIMS OF THE STUDY: Marketing authorisation of the bivalent respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) for maternal vaccination was predominantly based on safety and efficacy findings from the pivotal global phase 3 Maternal Immunization Study for Safety and Efficacy…

  2. Artikel Jurnal

    Modeling excess zeroes in an integrated analysis of vaccine safety

    Roger Maansson; David Radley; Qin Jiang dkk.

    Human Vaccines & Immunotherapeutics, Vol. 14 No. 6 · 2018 · Inggris · DOAJ Scopus

    In prophylactic vaccine studies in healthy populations, many subjects do not experience a single adverse event (AE). Thus, the number of AEs observed in such clinical trials may be difficult to model because of an excess of zeroes relative to the parametric distributions assumed. To determine which…

  3. Artikel Jurnal

    Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches

    Judith Absalon; Raphael Simon; David Radley dkk.

    Human Vaccines & Immunotherapeutics, Vol. 18 No. 1 · 2022 · Inggris · DOAJ Scopus

    Group B streptococcus (Streptococcus agalactiae, GBS) is an important cause of life-threatening disease in newborns. Pregnant women colonized with GBS can transmit the bacteria to the developing fetus, as well as to their neonates during or after delivery where infection can lead to sepsis…

  4. Artikel Jurnal Teks lengkap

    Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women

    Joaquin Luna; Manuel Plata; Mauricio Gonzalez dkk.

    PLoS ONE, Vol. 8 No. 12 · 2013 · Inggris · PLOS Scopus

    Background: Previous analyses from a randomized trial in women aged 24–45 have shown the quadrivalent HPV vaccine to be efficacious in the prevention of infection, cervical intraepithelial neoplasia (CIN) and external genital lesions (EGL) related to HPV 6/11/16/18 through 4 years. In this report…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal Teks lengkap

    Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine

    Kumar Ilangovan; David Radley; Michael Patton dkk.

    Vaccines, Vol. 13 No. 8 · 2025 · Inggris · DOAJ Scopus

    Background/objectives: This was a post hoc analysis of safety data across the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine clinical trial development program. Methods: Data from eight clinical trials in 46,913 immunocompetent adults who received RSVpreF or placebo were…

  6. Artikel Jurnal

    Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults

    Susan B. Manoff; Michele Sausser; Amy Falk Russell dkk.

    Human Vaccines & Immunotherapeutics, Vol. 15 No. 9 · 2019 · Inggris · DOAJ Scopus

    There is an unmet medical need for vaccines to prevent dengue. V180 is an investigational recombinant subunit vaccine that consists of truncated dengue envelope proteins (DEN-80E) for all 4 serotypes. Three dosage levels of the tetravalent DEN-80E antigens were assessed in a randomized…

  7. Artikel Jurnal

    From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

    John L. Perez; Judith Absalon; Johannes Beeslaar dkk.

    Expert Review of Vaccines, Vol. 17 No. 6 · 2018 · Inggris · DOAJ Scopus

    Introduction: Given the characteristics of meningococcal carriage and transmission and the sudden, often severe onset and long-term consequences of disease, vaccination can most effectively provide large-scale control of invasive disease. Six serogroups (A, B, C, W, X, and Y) cause nearly all…

  8. Artikel Jurnal

    MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

    Johannes Beeslaar; Judith Absalon; Annaliesa S. Anderson dkk.

    Infectious Diseases and Therapy, Vol. 9 No. 3 · 2020 · Inggris · DOAJ Scopus

    Abstract Introduction Two phase 3 studies in adolescents and young adults demonstrated that MenB-FHbp, a meningococcal serogroup B (MenB) vaccine, elicits protective immune responses after 2 or 3 doses based on serum bactericidal antibody assays using human complement (hSBA) against 4 primary and…

  9. Artikel Jurnal

    Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

    Susanne K. Kjaer; Mari Nygård; Karin Sundström dkk.

    EClinicalMedicine, Vol. 23 · 2020 · Inggris · DOAJ Scopus

    Background: The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy study (NCT00092534). We report long-term effectiveness and immunogenicity at the end of 14 years of follow-up after enrollment in…

  10. Artikel Jurnal Teks lengkap

    Safety, Tolerability, and Immunogenicity of RSVpreF Vaccine in Pregnant Individuals Living with HIV

    Landon Myer; Emily Wasserman; Saiqa Tabasum dkk.

    Vaccines, Vol. 13 No. 12 · 2025 · Inggris · DOAJ Scopus

    Background/Objectives: HIV-exposed uninfected (HEU) infants experience increased severe respiratory syncytial virus lower respiratory tract illness (RSV-LRTI) rates compared with HIV-unexposed infants. Maternal bivalent RSVpreF vaccination can prevent infant RSV-LRTI but data from HEU infants are…